Breast augmentation is one of the most personal surgical decisions a woman can make. Every patient deserves to understand the full picture before making that decision. Modern fifth-generation cohesive gel implants are safer and more natural-feeling than ever before — but choosing the right implant, the right technique, and the right surgeon requires real education, not just marketing.
تكبير الثدي قرار شخصي جدا. المريضة لازم تفهم كل التفاصيل — ده حقها وده واجبنا.
Silicone Gel (Cohesive — "Gummy Bear"): The most commonly used implant worldwide. Fifth-generation cohesive silicone gel maintains its shape even if the shell is compromised. It provides a natural feel and predictable outcomes. This is the standard of care in modern breast augmentation.
Saline Implants: Filled with sterile saltwater after placement. They allow smaller incisions and provide a built-in leak detection system — if the implant ruptures, the saline is safely absorbed by the body and the volume change is immediately visible. However, they tend to feel less natural than silicone, particularly in patients with thin tissue coverage.
Round vs. Anatomical (Teardrop): Round implants provide fullness in the upper pole and are more forgiving with positioning. Anatomical implants mimic the natural breast slope with more volume at the bottom. The choice depends on the patient's anatomy, tissue thickness, and aesthetic goals — not on trends.
Smooth vs. Textured Surface: Current medical evidence has shifted practice toward smooth implants in most cases, due to a very rare but documented association between textured surfaces and BIA-ALCL (breast implant-associated anaplastic large cell lymphoma). The evidence is discussed openly with every patient.
Size Selection: Proper size selection is based on tissue-based planning — chest width measurements, skin elasticity, and soft tissue coverage — not on asking patients to "pick a cup size." 3D imaging and sizer trials help patients visualize realistic outcomes before surgery.
The most common concern patients raise is: is silicone safe? This is an important question that deserves an honest, evidence-based answer — not reassurance or dismissal.
FDA and International Data: Multiple large-scale studies and systematic reviews, including FDA post-approval data, have found no proven causal link between silicone breast implants and systemic autoimmune diseases. Silicone implants were re-approved by the FDA in 2006 after extensive review and have remained approved with ongoing safety monitoring.
BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma): This is a rare but real risk. BIA-ALCL is not breast cancer — it is a type of lymphoma that develops in the scar tissue (capsule) around the implant. The vast majority of documented cases involve textured-surface implants. The estimated risk ranges from 1 in 2,000 to 1 in 86,000 depending on the implant type and surface texture. Early detection through routine monitoring leads to excellent outcomes — the condition is highly treatable when caught early.
Capsular Contracture: The most common long-term complication. The body naturally forms a thin capsule of scar tissue around any implant. In some patients, this capsule tightens excessively, causing firmness, discomfort, or shape distortion. Rates vary by technique and implant placement — submuscular (under the muscle) placement and careful surgical technique reduce the risk significantly. If it occurs, it can be treated surgically.
Breast Implant Illness (BII): Some patients report systemic symptoms they attribute to their implants — fatigue, brain fog, joint pain, and others. While current medical research has not established a definitive causal mechanism, these concerns are taken seriously. Patients who experience unexplained symptoms after augmentation deserve a thorough evaluation, not dismissal.
Transparency about risks builds trust. Everything is discussed — the benefits, the limitations, and the uncertainties — before surgery. An informed patient makes the best decisions.
Days 1-3: Rest is essential. You will experience swelling, tightness, and moderate soreness. Pain is managed with prescribed medication. Most patients describe the sensation as pressure rather than sharp pain.
Week 1: Soreness decreases significantly. Light daily activities can resume. A surgical support bra is worn continuously. No lifting above the shoulders.
Weeks 2-4: Most patients return to desk work and driving. Swelling continues to resolve. Implants will sit higher than their final position — this is normal.
Weeks 4-6: Gradual return to full activity including exercise. Lower-body workouts can resume first, with upper-body exercises introduced slowly.
Months 3-6: The "drop and fluff" phase — implants settle into their final position as the surrounding tissue relaxes. The breast shape softens and the lower pole fills out. This is when patients see their true final result.
Inframammary (under the breast fold): The most commonly used incision. It provides the most direct surgical access for precise implant placement and pocket creation. The scar is hidden in the natural crease beneath the breast and fades significantly over time. This approach gives the surgeon a high degree of control over the result.
Periareolar (around the areola): The incision follows the lower border of the areola where the darker skin meets the lighter breast skin. It heals well and is less visible in many patients. However, it carries a slightly higher risk of changes in nipple sensation and may not be suitable for larger implants.
The incision choice depends on your anatomy, implant type, and personal preferences, discussed in detail during consultation.
Most women with breast implants can breastfeed successfully. The ability depends primarily on the incision location and the surgical technique used:
• Inframammary incisions have the lowest impact on breastfeeding ability because they do not involve the breast tissue or milk ducts directly.
• Periareolar incisions carry a slightly higher risk of disrupting milk ducts and nerve supply to the nipple, though many patients with this incision breastfeed without difficulty.
• Submuscular placement (under the chest muscle) generally preserves more breast tissue function compared to subglandular (over the muscle) placement.
If breastfeeding is important to you — now or in the future — discuss it during consultation. The surgical plan can be tailored to minimise any impact on lactation.
Modern implants are designed to last 15-20 years, though many last longer. They are not considered lifetime devices — ongoing monitoring is recommended, and some patients may need revision surgery at some point.
The FDA recommends an MRI or ultrasound at 5-6 years after initial placement and every 2-3 years thereafter for silicone implants, to screen for silent rupture. A personalised monitoring schedule is discussed with every patient.
Pain is moderate and well-managed with medication. Most patients rate the discomfort as 4-5 out of 10 in the first few days, improving rapidly after the first week. Submuscular placement tends to involve more initial soreness than subglandular placement.
With proper planning, yes. Under-muscle (submuscular) placement provides a more natural contour and feel, particularly in patients with thinner tissue coverage. The key factors are appropriate implant size relative to your anatomy, correct placement, and a surgeon who prioritises proportion over volume.
Learn about the criteria you should verify before choosing a surgeon.
Every patient receives the standard pre-operative panel. Dr. Khaled Ghalwash adds personalised tests by profile (cardiac, diabetic, age over 50 with chronic disease).